Piramal Pharma Solutions opens dedicated OSD production capabilities at Sellersville, Pennsylvania site
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Subscribe To Our Newsletter & Stay Updated